血液学和生物化学参数对慢性慢性肺炎恶化不良临床过程和死亡率的预测值
Huseyin Kaya1, Serap Argun Baris, Esra Betul Kartal
1Department of Chest Diseases, Kocaeli University, Kocaeli, Turkey.
Medicine
|January 10, 2026
概括
中性细胞与淋巴细胞的比率 (NLR) 和血小板与淋巴细胞的比率 (PLR) 预测慢性阻塞性肺病 (COPD) 恶化的死亡率. 乳酸脱酶与蛋白比率 (LAR) 显示出潜力,但需要进一步研究COPD预后.
科学领域:
- 肺病学和呼吸系统医学
- 临床生物化学和生物标志物
- 关键护理医学 关键护理医学
背景情况:
- 慢性阻塞性肺病 (COPD) 是全球主要的健康负担,恶化导致显著的发病率和死亡率.
- 现有的生物标志物,如中性粒细胞与淋巴细胞的比率 (NLR),血小板与淋巴细胞的比率 (PLR) 和乙素与淋巴细胞的比率,有助于预测COPD恶化的结果.
- 乳酸脱酶与白蛋白比率 (LAR) 在COPD恶化中的预后价值仍未得到充分研究.
研究的目的:
- 评估乳酸脱酶与白蛋白比率 (LAR) 对住院COPD恶化患者不良临床结果和死亡率的预测能力.
- 为了评估NLR,PLR和欧素与淋巴细胞比率以及LAR在这个患者队列中的预后意义.
主要方法:
- 在2018年至2023年期间,对216名因COPD恶化而住院的患者进行了回顾性分析.
- 评估人口统计数据,并发病,实验室发现和临床结果,包括死亡率,非侵入性机械通风 (NIMV),ICU入院和住院时间.
- 使用多变量逻辑回归和接收器操作特征 (ROC) 曲线分析来确定生物标志物与结果的关联.
主要成果:
- 在接受ICU和死亡的患者中,NLR和PLR显著升高.
- 较高的NLR和PLR水平与急症监护室入院和住院死亡率的风险增加有关.
- 虽然LAR在需要氧气治疗和NIMV的患者中较高,但在本研究中,它与死亡率没有显著关联.
结论:
- 在COPD恶化中,NLR和PLR是ICU入院和住院死亡率的重要预测因素.
- 目前,LAR对COPD恶化的死亡率的预后价值尚不确定,需要进一步调查.
- 未来的研究应该专注于前性,多中心研究,并进行连续生物标志物监测,以提高预后准确性.
相关概念视频
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
01:26COPD: Management Using Bronchodilators and Corticosteroids
713
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
713
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K